Results 311 to 320 of about 159,317 (346)
Some of the next articles are maybe not open access.
Clonal dynamics of tumor-infiltrating lymphocytes
European Journal of Immunology, 2005The presence of tumor-infiltrating lymphocytes (TIL) provides important evidence of anti-tumor immunity in vivo. However, TIL are usually not sufficient for inhibiting tumor growth. We explored the spatial and temporal aspects of clonal accumulation of TIL using RT-PCR/single-strand conformation polymorphism analysis.
Hiroyuki Tahara+4 more
openaire +3 more sources
Tumor-Infiltrating Lymphocytes
Acta Cytologica, 1996To characterize the cytologic, phenotypic and morphometric features of tumor-infiltrating lymphocytes (TILs).Morphology and cell size parameters of 50 TILs and five normal donor peripheral blood lymphocyte (PBL) specimens were compared using light microscopy, manual ocular measurements and digital image processing.Cytologically, all TILs demonstrated ...
Diane Solomon+2 more
openaire +3 more sources
Reporting Tumor Infiltrating Lymphocytes
2012The presence of many tumor infiltrating lymphocytes (TILs) in primary cutaneous melanoma is associated with a better prognosis. The degree of lymphocytic interaction with the tumor cells is graded as “brisk”, “non-brisk” or “absent” as defined below:
Kasia Szyfelbein Masterpol+2 more
openaire +2 more sources
Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma
Gynecologic Oncology, 2021Polymerase-ε (POLE)-mutated endometrial carcinomas (ECs) have displayed an increased number of tumor-infiltrating lymphocytes (TIL) compared to POLE-wild-type ECs. However, it is unclear if TIL may aid in identifying POLE-mutated ECs when molecular data are unavailable.
Raffone A.+10 more
openaire +5 more sources
Tumor-Infiltrating Lymphocyte Therapy and Neoantigens
The Cancer Journal, 2017The adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes has been shown to be effective at mediating tumor regression in more than half of patients with metastatic melanoma and in mediating long-term complete regression in approximately one fourth of all patients with this cancer.
openaire +3 more sources
Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms [PDF]
Tumor-infiltrating lymphocytes (TIL) are considered important in anticancer immunosurveillance, although their role has not been clearly established yet. We examined prevalence, correlations, and prognostic significance of TIL among our patient population of resected lung neoplasms.From 1993 to 2006, the presence of TIL was retrospectively evaluated in
RUFFINI, Enrico+7 more
openaire +3 more sources
Immunotyping and Quantification of Melanoma Tumor–Infiltrating Lymphocytes
2021The density of tumour-infiltrating lymphocytes (TILs) in melanoma is correlated with improved clinical prognosis; however, standardized TIL immunotyping and quantification protocols are lacking. Herein, we provide a review of the technologies being utilized for the immunotyping and quantification of melanoma TILs.
Zeyad T. Sahli+4 more
openaire +3 more sources
Tumor-infiltrating lymphocytes: A new hope
Cancer CellTumor-infiltrating lymphocytes (TILs) can be massively expanded from resected tumors and used as a cellular treatment for advanced malignancies. TILs require a preparative non-myeloablative chemotherapy followed by an abbreviated course of interleukin-2.
Amod A, Sarnaik+3 more
openaire +2 more sources
Predictors of Tumor-Infiltrating Lymphocyte Efficacy in Melanoma
Immunotherapy, 2015In the past decades, the increasing knowledge in cellular immunology and tumor-host immune interactions, led to the development of immunotherapy approaches. Immunotherapy, based on adoptive cell transfer of ex vivo activated and expanded tumor-infiltrating T lymphocytes (TILs), has shown promising clinical results in patients with metastatic melanoma ...
Michal J. Besser+3 more
openaire +3 more sources
Immunopriming of Tumor Infiltrating Lymphocytes with Neoadjuvant Cyclophosphamide
Immunological Investigations, 1993Tumor infiltrating lymphocytes (TIL) are increasingly employed in immunotherapy protocols. When modified and expanded they can be utilized in new therapeutic protocols. TIL augmentation can be in vitro and in vivo. The purpose of this article is to review the various methods of TIL augmentation and report our experience with a neoadjuvant technique of ...
M. Rubenstein, M. Shaw, P. Guinan
openaire +3 more sources